OCUL — Ocular Therapeutix Inc
In 2026 Q2, 3 of the 140 tracked hedge funds reported a position in Ocular Therapeutix Inc (OCUL), worth $9.15M combined. Over the quarter 1 opened or added, 3 trimmed or exited.
Hedge fund holders, 2026 Q2
| Fund | Value | Portfolio % | Change |
|---|---|---|---|
| Essex | $4.73M | 0.62% | +22.8% |
| Renaissance | $3.72M | 0.00% | -67% |
| Ratan | $695.18K | 0.22% | -62.5% |
All stocks · Quarterly Trends · Hedge Fund Tracker
Source: SEC EDGAR 13F filings, reported as of quarter end and filed up to 45 days later. Not investment advice.